Literature DB >> 11175747

RANTES promotes growth and survival of human first-trimester forebrain astrocytes.

M Bakhiet1, A Tjernlund, A Mousa, A Gad, S Strömblad, W A Kuziel, A Seiger, J Andersson.   

Abstract

We have examined the role of alpha and beta chemokines in the promotion of the ontogenetic development of the brain. RANTES was expressed preferentially in human fetal astrocytes in an age-dependent manner. Astrocytes from 5-week-old brains showed high proliferation and reduced survival, whereas 10-week-old astrocytes exhibited opposite effects. These effects were suppressed by anti-RANTES or anti-RANTES receptor antibodies and were enhanced by recombinant RANTES. RANTES induced tyrosine phosphorylation of several cellular proteins and nuclear translocation of STAT-1 in astrocytes. Interferon-gamma (IFN-gamma) was required for RANTES effects because RANTES induced IFN-gamma and only 10-week-old astrocytes expressed the IFN-gamma receptor. Blocking of IFN-gamma with antibody reversed the effects of RANTES, indicating that cytokine/chemokine networks are critically involved in brain development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11175747     DOI: 10.1038/35055057

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  23 in total

Review 1.  Chemokines--linking receptors to response.

Authors:  Malcolm L Watson
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

Review 2.  Chemokines and glial cells: a complex network in the central nervous system.

Authors:  Elena Ambrosini; Francesca Aloisi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

Review 3.  Neuronal chemokines: versatile messengers in central nervous system cell interaction.

Authors:  A H de Haas; H R J van Weering; E K de Jong; H W G M Boddeke; K P H Biber
Journal:  Mol Neurobiol       Date:  2007-07-10       Impact factor: 5.590

4.  Oncogenic H-Ras V12 promotes anchorage-independent cytokinesis in human fibroblasts.

Authors:  Minna Thullberg; Annica Gad; Sylvie Le Guyader; Staffan Strömblad
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

5.  Pharmacological induction of CCL5 in vivo prevents gp120-mediated neuronal injury.

Authors:  Lee A Campbell; Valeriya Avdoshina; Chris Day; Seung T Lim; Italo Mocchetti
Journal:  Neuropharmacology       Date:  2015-01-23       Impact factor: 5.250

6.  Upregulation of RANTES gene expression in neuroglia by Japanese encephalitis virus infection.

Authors:  Chun-Jung Chen; Jian-Hong Chen; Shih-Yun Chen; Su-Lan Liao; Shue-Ling Raung
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Purification and biochemical characterization of the D6 chemokine receptor.

Authors:  Paul E Blackburn; Clare V Simpson; Robert J B Nibbs; Maureen O'Hara; Rhona Booth; Jemma Poulos; Neil W Isaacs; Gerard J Graham
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

8.  CCL5 and cytokine expression in the rat brain: differential modulation by chronic morphine and morphine withdrawal.

Authors:  Lee A Campbell; Valeriya Avdoshina; Summer Rozzi; Italo Mocchetti
Journal:  Brain Behav Immun       Date:  2013-08-19       Impact factor: 7.217

9.  Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis.

Authors:  S Prahalad
Journal:  Genes Immun       Date:  2006-04       Impact factor: 2.676

10.  CCL5 secreted by senescent aged fibroblasts induces proliferation of prostate epithelial cells and expression of genes that modulate angiogenesis.

Authors:  D Eyman; M Damodarasamy; S R Plymate; M J Reed
Journal:  J Cell Physiol       Date:  2009-08       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.